Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

Authors :: John V. Heymach
Nishan Tchekmedyian
Bill Paxton
Lena Keossayan
Francois Lebel
Source :: JTO Clinical and Research Reports, JTO Clinical and Research Reports, Vol 1, Iss 4, Pp 100081-(2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: Pulmonary and Respiratory Medicine
business.industry
First line
Central nervous system
Mutant
Poziotinib
Case Report
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282
medicine.anatomical_structure
Oncology
Cancer research
Medicine
business

Tools